
During the Health System Executive Summit, Candy Tsourounis, PharmD, and Elise Wozniak, PharmD got candid about the barriers and financial risk surrounding this innovative therapy.
FDA rolls out new policies on DTC advertising,counterfeit drugs, and bar codes before McClellan departs






